Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia

Summary

The purpose of this study is to evaluate the safety, pharmacodynamics and pharmacokinetics of repeat doses of orally administered AKB-6548 in pre-dialysis participants with anemia.

Timeline

Start

2010-10-21

Primary completion

2011-04-13

Completion

2011-05

Drugs

Indications